Pfizer to Acquire Obesity Drug Start-Up Metsera in $10 Billion Deal
In a significant development within the pharmaceutical industry, Pfizer has successfully acquired Metsera, a biotech company specializing in innovative treatments,…
Read more →
In a significant development within the pharmaceutical industry, Pfizer has successfully acquired Metsera, a biotech company specializing in innovative treatments,…
Read more →
Recent research has revealed that selective serotonin reuptake inhibitors (S.S.R.I.s), commonly prescribed antidepressants, can significantly dampen sexual desire in adults.…
Read more →
In a significant advancement for cardiovascular health, Merck has announced promising results from its latest clinical trial involving a new…
Read more →
Dr. Richard Pazdur has been appointed as the new head of the Center for Drug Evaluation and Research (CDER) at…
Read more →
At a recent international conference, leading researchers in the field of animal-human transplantation convened to share their groundbreaking findings and…
Read more →
On November 6, 2025, an independent taskforce released its comprehensive final report aimed at addressing the multifaceted challenges faced by…
Read more →
In June 2023, the U.S. Food and Drug Administration (FDA) made a significant move by suspending new clinical trials that…
Read more →
In an innovative initiative aimed at fostering dialogue on climate change, the New York Times has launched a new series…
Read more →
In a compelling narrative that underscores the importance of mental health awareness, a man’s long struggle with intermittent symptoms culminated…
Read more →
Recent studies have shed light on the impact of nighttime workouts on sleep quality, revealing a nuanced relationship between exercise…
Read more →